{"id":129222,"date":"2026-06-04T04:07:24","date_gmt":"2026-06-04T04:07:24","guid":{"rendered":"https:\/\/www.europesays.com\/be-fr\/129222\/"},"modified":"2026-06-04T04:07:24","modified_gmt":"2026-06-04T04:07:24","slug":"une-entreprise-liegeoise-sattaque-a-la-perte-daudition-liee-a-lage","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/be-fr\/129222\/","title":{"rendered":"Une entreprise li\u00e9geoise s&rsquo;attaque \u00e0 la perte d&rsquo;audition li\u00e9e \u00e0 l&rsquo;\u00e2ge"},"content":{"rendered":"<p class=\"ap-StoryElement ap-StoryElement--mb ap-StoryText\">Le DX243 appartient \u00e0 une nouvelle g\u00e9n\u00e9ration de petites mol\u00e9cules first in class, nomm\u00e9es les \u00ab\u00a0dendrog\u00e9nines\u00a0\u00bb. Cette nouvelle entit\u00e9 chimique (NCE) pr\u00e9sente des propri\u00e9t\u00e9s neuroprotectrices et neurog\u00e9n\u00e9ratrices. \u00ab\u00a0Compte tenu de son m\u00e9canisme d&rsquo;action remarquable, le DX243 pr\u00e9sente un fort potentiel th\u00e9rapeutique pour le traitement de nombreuses pathologies li\u00e9es \u00e0 une atteinte neuronale, incluant la perte d&rsquo;audition ou encore d&rsquo;autres indications potentielles comme les maladies neurod\u00e9g\u00e9n\u00e9ratives cons\u00e9cutives \u00e0 un accident vasculaire c\u00e9r\u00e9bral isch\u00e9mique et les traumatismes cr\u00e2niens\u00a0\u00bb, indique la biotech bas\u00e9e au CHU de Li\u00e8ge.<\/p>\n","protected":false},"excerpt":{"rendered":"Le DX243 appartient \u00e0 une nouvelle g\u00e9n\u00e9ration de petites mol\u00e9cules first in class, nomm\u00e9es les \u00ab\u00a0dendrog\u00e9nines\u00a0\u00bb. Cette nouvelle&hellip;\n","protected":false},"author":2,"featured_media":129223,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[82],"tags":[12,13,18,17,19659,86,87],"class_list":["post-129222","post","type-post","status-publish","format-standard","has-post-thumbnail","category-sante","tag-be","tag-be-fr","tag-belgique","tag-belgium","tag-biotech","tag-health","tag-sante"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@be_fr\/116689872207258513","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/posts\/129222","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/comments?post=129222"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/posts\/129222\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/media\/129223"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/media?parent=129222"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/categories?post=129222"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/be-fr\/wp-json\/wp\/v2\/tags?post=129222"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}